BORA PHARMACEUTICALS LTD Capital Reinvestment Ratio
BORA PHARMACEUTICALS LTD capital reinvestment ratio. BORA PHARMACEUTICALS LTD (6472) has a Capital Reinvestment Ratio of 0.37x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$568.46 Million) in capital expenditures (NT$211.08 Million). Check 6472 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BORA PHARMACEUTICALS LTD (2019–2025)
Capital reinvestment ratio of BORA PHARMACEUTICALS LTD from 2019 to 2025. This chart tracks BORA PHARMACEUTICALS LTD's Capital Reinvestment Ratio across 7 annual periods. Also explore net asset momentum of BORA PHARMACEUTICALS LTD to track the company's year-over-year net asset growth rate.
BORA PHARMACEUTICALS LTD Capital Reinvestment Ratio by Year (2019–2025)
BORA PHARMACEUTICALS LTD capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see 6472 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | NT$4.24 Billion | NT$928.67 Million | ▼ -68.7% |
| 2024 | 0.70x | NT$980.81 Million | NT$687.05 Million | ▲ +126.0% |
| 2023 | 0.31x | NT$4.61 Billion | NT$1.43 Billion | ▲ +211.2% |
| 2022 | 0.10x | NT$2.01 Billion | NT$200.22 Million | ▼ -66.1% |
| 2021 | 0.29x | NT$1.24 Billion | NT$363.58 Million | ▼ -65.6% |
| 2020 | 0.86x | NT$177.79 Million | NT$152.09 Million | ▼ -71.6% |
| 2019 | 3.01x | NT$231.77 Million | NT$697.33 Million | — |